Global Cellular Immunotherapy Market Report: Size, Share, Trends, Growth, Technology, Application, Analysis And Forecast To 2031

The global cellular immunotherapy market size is expected to grow from $3.68 billion in 2021 to $4.30 billion in 2022 at a compound annual growth rate (CAGR) of 17%. The growth in the market is mainly due to the companies resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The cellular immunotherapy market is expected to reach $7.60 billion in 2026 at a CAGR of 15.3%.

The Business Research Company offers the Cellular Immunotherapy Global Market Report 2022 in its research report store. It is the most comprehensive report available on this market and will help gain a truly global perspective as it covers 60 geographies. The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by region and by country. It also compares the market's historic and forecast growth, and highlights important trends and strategies that players in the market can adopt.

Directly Purchase The Report Here: https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3435

The cellular immunotherapy market consists of revenues generated by the companies engaged in developing, manufacturing, and sales of cellular immunotherapy drugs. Cellular immunotherapy is also known as adoptive cell therapy, a form of treatment that utilizes the cells of the immune system to eliminate diseases including non-Hodgkin lymphoma, cancer, and acute lymphoblastic leukaemia.

Some key cellular immunotherapy market players are Novartis AG, Gilead Sciences Inc. (Kite Pharma), Apac Biotech, Dendreon Pharmaceuticals LLC, JW CreaGene Co. Ltd, Green Cross Corp (GC Pharma), AstraZeneca, Bristol-Myers Squibb, Pfizer Inc. and Roche

The countries covered in the global cellular immunotherapy market are Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, China, Colombia, Czech Republic, Denmark, Egypt, Finland, France, Germany, Hong Kong, India, Indonesia, Ireland, Israel, Italy, Japan, Malaysia, Mexico, Netherlands, New Zealand, Nigeria, Norway, Peru, Philippines, Poland, Portugal, Romania, Russia, Saudi Arabia, Singapore, South Africa, South Korea, Spain, Sweden, Switzerland, Thailand, Turkey, UAE, UK, USA, Venezuela, Vietnam.

The regions covered in the global cellular immunotherapy market are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Cellular Immunotherapy Market Segmentation:
By Therapy
1.Tumour-Infiltrating Lymphocyte (TIL) Therapy
2.Engineered T Cell Receptor (TCR) Therapy
3.Chimeric Antigen Receptor (CAR) T Cell Therapy
4.Natural Killer (NK) Cell Therapy

By Primary Indication
1.B-Cell Malignancies
2.Prostate Cancer
3.Renal Cell Carcinoma
4.Liver Cancer
5.Non-Hodgkin Lymphoma

By Application
1.Prostate Cancer
2.Breast Cancer
3.Skin Cancer
4.Ovarian Cancer
5.Brain Tumour
6.Lung Cancer

See More On The Report At https://www.thebusinessresearchcompany.com/report/cellulars-immunotherapy-global-market-report

The Report's Table Of Contents includes
1. Executive Summary
2. Cellular Immunotherapy Market Characteristics
3. Cellular Immunotherapy Market Trends And Strategies
4. Impact Of COVID-19 On Cellular Immunotherapy
5. Cellular Immunotherapy Market Size And Growth
......
27. Cellular Immunotherapy Market Competitive Landscape And Company Profiles
28. Cellular Immunotherapy Pipeline Analysis
29. Key Mergers And Acquisitions In The Cellular Immunotherapy Market
30. Cellular Immunotherapy Market Future Outlook and Potential Analysis
31. Appendix

This report covers the trends and market dynamics of the cellular immunotherapy market in major countries - Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, and USA. The report also includes consumer surveys and various future opportunities for the market.

Request For A Sample Of This Report: https://www.thebusinessresearchcompany.com/sample.aspx?id=3435&type=smp

Contact Information:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info

Check out our blog: http://blog.tbrc.info/
And follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

About Us:
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that excels in company, market, and consumer research. It has published over 3000 industry reports, covering over 2500 market segments and 60 geographies. The reports draw on 150,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders. The reports are updated with a detailed analysis of the impact of COVID-19 on various markets.

This release was published on openPR.